Gsk GSK Income Statement (2009-2026)

NYSE GSK
$50.11 +1.98 (+4.11%)
As of: Sep 14, 2026 · 12:29 PM EDT
Reported Financials

Gsk Quarterly Income Statement

Periods 71 quarters
Latest Sep 2026

Gsk reported revenue of $21.53B and net income of $3.21B for the quarter ended Sep 2026, up 86.7% year over year. This income statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
14.82B9.65B8.73B9.23B16.56B8.45B8.98B10.32B17.54B9.34B9.95B10.41B19.57B9.47B10.65B11.53B20.62B10.29B11.28B21.53B
Cost of RevenueCost of Rev
4.53B3.65B2.74B2.86B11.21B2.36B2.42B2.88B10.63B2.50B2.68B3.11B11.61B2.44B2.89B3.05B11.99B2.53B3.04B5.56B
Gross Profit
10.29B6.00B5.99B6.37B10.82B6.09B6.56B7.44B12.73B6.84B7.27B7.30B14.32B7.03B7.77B8.49B15.16B7.76B8.24B15.97B
Operating items
Amortization - Intangibles
Operating Interest ExpensesOp. Interest Exp.
Research & DevelopmentR&D
-3.00B-1.48B-1.56B-1.59B-6.44B-1.53B-1.68B-2.00B-7.72B-1.82B-1.86B-1.90B-8.22B-1.84B-2.70B-2.28B-10.01B-2.28B-4.65B-6.93B
Selling, General & AdministrativeSG&A
-4.31B-2.43B-2.60B-2.42B-9.82B-2.60B-2.84B-2.91B-11.65B-2.65B-3.11B-4.94B-14.14B-2.61B-2.85B-3.02B-12.09B-2.86B-2.95B-5.80B
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
-0.49B0.80B-0.66B-1.26B0.89B0.36B0.35B-0.46B0.71B-0.68B-0.40B-0.44B-1.96B-0.01B0.16B0.03B-0.16B0.21B-0.27B-0.06B
Operating ExpensesOpex
-7.31B-3.91B-4.17B-4.01B-16.26B-4.14B-4.52B-4.90B-19.37B-4.47B-4.98B-6.83B-22.35B-4.45B-5.55B-5.30B-22.10B-5.14B-7.60B-12.73B
Operating IncomeOp. Inc
3.35B3.08B1.36B1.40B3.96B2.53B2.68B2.47B5.24B1.89B2.08B0.25B4.03B2.79B2.70B3.50B5.64B3.09B0.65B3.72B
EBIT
3.35B3.08B1.36B1.40B3.96B2.53B2.68B2.47B5.24B1.89B2.08B0.25B4.03B2.79B2.70B3.50B5.64B3.09B0.65B3.72B
Non-operating items
Non Operating Interest Expenses
-0.52B-0.28B-0.26B-0.24B-1.03B-0.25B-0.23B-0.23B-0.98B-0.21B-0.22B-0.20B-0.86B-0.20B-0.25B-0.23B-0.93B-0.23B-0.24B-0.47B
Interest & Investment IncomeInt & Inv Inc
0.01B0.01B0.03B0.03B0.03B0.04B0.04B0.03B0.08B0.04B0.03B0.04B0.07B0.07B0.07B0.04B0.14B0.03B0.08B0.11B
Non Operating IncomeNon Op. Inc.
1.02B
Net income details
EBT
2.84B2.81B1.13B1.19B3.51B2.32B2.49B2.27B4.83B1.72B1.89B0.08B3.66B2.66B2.52B3.31B5.31B2.89B0.47B3.35B
Tax ProvisionsTaxes
0.16B-0.43B-0.19B-0.27B-0.83B-0.34B-0.30B-0.33B-0.94B-0.35B-0.24B0.00B-0.68B-0.42B-0.32B-0.42B-1.48B-0.41B0.27B-0.14B
Profit After TaxPAT
4.74B2.91B0.94B0.92B2.95B1.98B2.18B2.10B4.19B1.37B2.13B0.08B3.06B2.23B2.84B3.74B4.55B2.48B0.21B3.21B
Equity Income
0.04B-0.00B-0.00B-0.00B-0.00B
Income from Non-Controlling InterestsInc. Minority
6.87B2.91B1.23B12.80B18.32B1.98B2.18B1.94B6.59B1.37B1.65B0.08B3.79B2.23B2.20B2.89B8.37B2.48B0.74B3.21B
Income from Continuing OperationsIncome (Continuing)
2.68B3.24B1.32B1.47B4.34B2.65B2.79B2.59B5.77B2.07B2.13B0.08B4.33B3.08B2.84B3.74B6.79B3.30B0.21B3.50B
Income from Discontinued OperationsIncome (Discontinued)
2.13B0.53B0.29B11.88B12.55B
Consolidated Net IncomeConsol Net Inc.
4.81B3.77B1.61B13.35B16.89B2.65B2.79B2.59B5.77B2.07B2.13B0.08B4.33B3.08B2.84B3.74B6.79B3.30B0.21B3.50B
Income towards Parent CompanyParent Net Inc
3.33B2.42B1.06B12.75B3.10B1.81B2.03B1.85B3.86B1.33B1.48B-0.08B2.85B2.05B1.93B2.72B4.08B2.34B0.58B2.92B
Net Income towards Common StockholdersNet Income
3.33B2.42B1.06B12.75B3.10B1.81B2.03B1.85B3.86B1.33B1.48B-0.08B2.85B2.05B1.93B2.72B4.08B2.34B0.58B2.92B
Additional items
EPS (Basic)
1.661.210.536.371.540.901.010.921.910.650.73-0.041.401.000.941.332.011.160.291.44
EPS (Diluted)
1.641.190.526.291.520.891.000.911.880.650.72-0.041.380.990.931.311.981.140.281.42
Shares Outstanding
2.00B2.00B2.00B2.00B2.01B2.01B2.01B2.01B2.03B2.03B2.03B2.03B2.04B2.04B2.04B2.04B2.03B2.03B2.03B2.03B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.03B2.03B2.03B2.03B2.04B2.04B2.04B2.04B2.06B2.06B2.06B2.06B2.07B2.07B2.07B2.07B2.06B2.06B2.06B2.06B
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.15B2.16B2.16B2.16B2.16B
EBITDA
3.35B3.08B1.36B1.40B3.96B2.53B2.68B2.47B5.24B1.89B2.08B0.25B4.03B2.79B2.70B3.50B5.64B3.09B0.65B3.72B
Interest ExpensesInt Expense
-0.52B-0.28B-0.26B-0.24B-1.03B-0.25B-0.23B-0.23B-0.98B-0.21B-0.22B-0.20B-0.86B-0.20B-0.25B-0.23B-0.93B-0.23B-0.24B-0.47B
Tax Rate
5.56%-15.43%-16.74%-23.02%-23.65%-14.47%-12.18%-14.35%-19.41%-20.22%-12.78%1.56%-18.46%-15.94%-12.77%-12.70%-27.83%-14.23%56.21%-4.24%